|
| Exchange Disseminated Time 23/05/2016 10:20:45 | Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider the following:
1. To Consider and Approve the Audited financial results for the quarter/year ended March 31, 2016.
2. To Recommend dividend, if any, for the year ended March 31, 2016.
Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for dealing in the securities of the Company for all the persons defined under the said Regulations including Director/Officer and Employees of the Company from May 23rd, 2016 till 48hrs from the date of declaration of the Audited Financial Results for the Quarter and Year ended March 31, 2016. (June 01, 2016) |
|
|